ADVANC:SETAdvanced Info Service Public Co., Ltd. Analysis
Data as of 2026-09-08 - not real-time
$477.57
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $477.57, Advanced Micro Devices, Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 8.5%. RSI sits at 49.7, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $440.50 and resistance at $517.35.
Multiples put this in overvalued territory: 121.8 times earnings against the sector's 33.2. Consensus targets land 28.5% above where the shares trade now. Revenue is growing at 50.1% on a 15.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 69.0%, a beta of 3.13 and a maximum drawdown of 27.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Multiples put this in overvalued territory: 121.8 times earnings against the sector's 33.2. Consensus targets land 28.5% above where the shares trade now. Revenue is growing at 50.1% on a 15.6% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 69.0%, a beta of 3.13 and a maximum drawdown of 27.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
AMD is riding AI momentum with major partnerships and a 34% revenue surge, while Intel battles losses and restructuring.AMD boasts superior margins and lower leverage, while AppLovin trades at a fraction of the valuation multiple despite...Advanced Micro Devices, Inc. NASDAQ:AMD is one of the 10 Best Stocks to Buy in Glen Kacher’s Light Street Portfolio....
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 341.00
- MACD momentum is positive
- 30-day price change of -8.5%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 121.8 versus sector average of 33.2
- Trading above the 200-day average of 341.00
- Analyst targets imply +28.5% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 121.8 versus sector average of 33.2
- Analyst targets imply +28.5% versus the current price
- Profit margin of 15.6% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth50.10%
Profit Margin15.58%
P/E Ratio121.8
ROE10.20%
ROA5.13%
Debt/Equity6.36
P/B Ratio11.6
Op. Cash Flow$10.1B
Free Cash Flow$8.8B
Industry P/E33.2
Technical Analysis
TrendNeutral
RSI49.7
Support$440.50
Resistance$517.35
MA 20$475.20
MA 50$499.27
MA 200$341.00
MACDBullish
VolumeDecreasing
Fear & Greed Index93.95
Valuation
Fair Value$192.30
Target Price$613.84
Upside/Downside28.54%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.13
Volatility69.05%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.